A recent study compared the performance of Avastin, a cancer treatment drug and Ludentis, a drug used to treat a degenerative eye disease, which showed that both drugs performed with the same level of efficiency in treating age-related macular degeneration.
Patients who received monthly doses of Avastin were benefitted by a 8.0 letters of visual acuity as compared to an 8.5 letter improvement produced by the drug Ludentis.
AdvertisementBoth drugs are manufactured by the same company, Genentech, but are differently priced.
While a single dose of Avastin costs about $50, patients will have to cough up so much more for a single dose of Ludentis, priced at about $2,000.
You May Also Like